Latest Videos |view all videos
Treatment options for advanced kidney cancer
Bradley C. Leibovich, M.D., a urologic surgeon specializing in the treatment of kidney cancer at Mayo Clinic in Rochester, Minnesota, discusses the symptoms that patients with kidney tumors may — or may not — experience, as well as treatment ...
Clinical trial regarding endometrial cancer and stress urinary incontinence
Gynecologic oncologist Gretchen E. Glaser, M.D., with Mayo Clinic in Rochester, Minnesota, discusses a study that compares the quality of life and clinical outcomes among women with endometrial cancer and stress urinary incontinence who ...
A multidisciplinary approach to genitourinary cancers
Mayo Clinic specialists describe considerations and advancements in surgical techniques used in the treatment of testicular cancer, bladder cancer and kidney cancer.
Bladder cancer treatment options
R. Jeffrey Karnes, M.D., consultant and associate professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into subcategories, and the treatments dramatically differ. Invasive treatments can ...
Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients
Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.
Mayo Clinic expert says heart disease from unnecessarily treating "Low T" serious concern
Low T — health risks of testosterone therapy —- Mayo Clinic. William F. Young Jr., M.D.
Zebrafish Discovery May Shed Light on Human Kidney Function
Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo Clinic and the Tokyo Institute of Technology ...
Minority disparities evident in prostate cancer survival rate, Mayo Clinic study shows
A Mayo Clinic study reviewed data on more than 290,000 men with prostate cancer from the past 20 years and found that African-American men are at increased risk of poorer survival rate following prostate cancer treatment compared with other minority groups.
Needle-guided tumor destruction procedures offer near-equivalent lengths of local cancer control compared with surgery for patients with small kidney cancer tumors, according to the results of a large study published in the journal European Urology.